Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies Medtronic , a global leader in healthcare technology, announced its intent
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting
With the increase in life expectancy, people need more medical help and care. AI-enabled technologies can help people to live healthier and longer lives. Global
Fuel up with free Health Tech Insights
